Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberculosis | 2 | 2023 | 124 | 1.250 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2023 | 18 | 0.820 |
Why?
|
| Phytol | 3 | 2013 | 3 | 0.800 |
Why?
|
| Adjuvants, Immunologic | 3 | 2013 | 169 | 0.730 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2023 | 202 | 0.680 |
Why?
|
| Staphylococcus aureus | 2 | 2013 | 282 | 0.640 |
Why?
|
| Killer Cells, Natural | 1 | 2018 | 277 | 0.520 |
Why?
|
| Lymphocytes | 1 | 2018 | 476 | 0.510 |
Why?
|
| Diterpenes | 2 | 2013 | 22 | 0.450 |
Why?
|
| Cellular Microenvironment | 2 | 2012 | 30 | 0.440 |
Why?
|
| Disease Progression | 1 | 2018 | 1505 | 0.430 |
Why?
|
| Alum Compounds | 1 | 2013 | 5 | 0.410 |
Why?
|
| Staphylococcal Vaccines | 1 | 2013 | 17 | 0.400 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 628 | 0.380 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2022 | 60 | 0.360 |
Why?
|
| Intestine, Small | 1 | 2012 | 301 | 0.350 |
Why?
|
| Cytokines | 4 | 2019 | 843 | 0.340 |
Why?
|
| Immunity, Innate | 2 | 2012 | 441 | 0.340 |
Why?
|
| T-Lymphocytes | 2 | 2022 | 1279 | 0.300 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 815 | 0.280 |
Why?
|
| Coronary Artery Disease | 1 | 2022 | 379 | 0.270 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 419 | 0.260 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 67 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2023 | 108 | 0.190 |
Why?
|
| Vaccines | 1 | 2013 | 82 | 0.180 |
Why?
|
| Omalizumab | 1 | 2021 | 8 | 0.180 |
Why?
|
| Chemokines | 1 | 2011 | 74 | 0.180 |
Why?
|
| Peanut Hypersensitivity | 1 | 2021 | 17 | 0.180 |
Why?
|
| Antigens | 2 | 2022 | 228 | 0.160 |
Why?
|
| GPI-Linked Proteins | 1 | 2018 | 53 | 0.150 |
Why?
|
| South Africa | 1 | 2018 | 60 | 0.150 |
Why?
|
| Latent Tuberculosis | 1 | 2018 | 17 | 0.150 |
Why?
|
| Receptors, IgG | 1 | 2018 | 56 | 0.150 |
Why?
|
| Internationality | 1 | 2018 | 71 | 0.150 |
Why?
|
| Adolescent | 2 | 2023 | 9495 | 0.140 |
Why?
|
| Inflammasomes | 2 | 2012 | 29 | 0.140 |
Why?
|
| China | 1 | 2018 | 248 | 0.140 |
Why?
|
| Lymphocyte Activation | 2 | 2022 | 786 | 0.140 |
Why?
|
| Pneumonia | 1 | 2018 | 187 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 2 | 2013 | 1108 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1117 | 0.110 |
Why?
|
| Vaccines, Inactivated | 1 | 2013 | 29 | 0.100 |
Why?
|
| Transcriptome | 1 | 2018 | 700 | 0.100 |
Why?
|
| CD30 Ligand | 1 | 2012 | 2 | 0.100 |
Why?
|
| Chemokine CX3CL1 | 1 | 2012 | 6 | 0.100 |
Why?
|
| Guided Tissue Regeneration | 1 | 2012 | 7 | 0.100 |
Why?
|
| Chemokines, CC | 1 | 2012 | 37 | 0.100 |
Why?
|
| Antibodies, Bacterial | 1 | 2013 | 103 | 0.100 |
Why?
|
| HLA-DR alpha-Chains | 1 | 2022 | 4 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 161 | 0.090 |
Why?
|
| Clone Cells | 1 | 2022 | 214 | 0.090 |
Why?
|
| Th2 Cells | 1 | 2012 | 148 | 0.090 |
Why?
|
| Th1 Cells | 1 | 2012 | 168 | 0.090 |
Why?
|
| Mice | 3 | 2013 | 12136 | 0.090 |
Why?
|
| Epitopes | 1 | 2022 | 249 | 0.090 |
Why?
|
| Wound Healing | 1 | 2012 | 371 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 280 | 0.080 |
Why?
|
| Humans | 6 | 2023 | 92339 | 0.080 |
Why?
|
| Clonal Selection, Antigen-Mediated | 1 | 2019 | 8 | 0.080 |
Why?
|
| Mucosal-Associated Invariant T Cells | 1 | 2019 | 11 | 0.080 |
Why?
|
| Sequence Analysis | 1 | 2019 | 27 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2022 | 472 | 0.080 |
Why?
|
| Natural Killer T-Cells | 1 | 2019 | 46 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 248 | 0.070 |
Why?
|
| Animals | 3 | 2013 | 28053 | 0.060 |
Why?
|
| Models, Biological | 1 | 2012 | 1786 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2018 | 8730 | 0.060 |
Why?
|
| Base Sequence | 1 | 2019 | 2319 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 2007 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2019 | 2905 | 0.050 |
Why?
|
| Female | 3 | 2013 | 47893 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2013 | 139 | 0.050 |
Why?
|
| Ascitic Fluid | 1 | 2011 | 38 | 0.050 |
Why?
|
| Protein Array Analysis | 1 | 2011 | 52 | 0.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2011 | 25 | 0.040 |
Why?
|
| Desensitization, Immunologic | 1 | 2021 | 43 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 2021 | 148 | 0.040 |
Why?
|
| Vaccination | 1 | 2013 | 286 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 298 | 0.040 |
Why?
|
| Allergens | 1 | 2021 | 189 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2021 | 672 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 888 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2011 | 680 | 0.040 |
Why?
|